Cargando…

Prednisolone versus placebo addition in the treatment of patients with recent-onset psychotic disorder: a trial design

BACKGROUND: The symptom severity of a substantial group of schizophrenia patients (30–40%) does not improve through pharmacotherapy with antipsychotic medication, indicating a clear need for new treatment options to improve schizophrenia outcome. Meta-analyses, genetic studies, randomized controlled...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nasib, Lyliana G., Sommer, Iris E., Winter - van Rossum, Inge, de Vries, Jacqueline, Gangadin, Shiral S., Oomen, Priscilla P., Judge, Gurmeet, Blom, Renske E., Luykx, Jurjen J., van Beveren, Nico J. M., Veen, Natalie D., Kroken, Rune A., Johnsen, Erik L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7278136/ https://www.ncbi.nlm.nih.gov/pubmed/32513294 http://dx.doi.org/10.1186/s13063-020-04365-4

Ejemplares similares

T43. PREDNISOLONE VERSUS PLACEBO AS AUGMENTATION THERAPY IN PSYCHOTIC DISORDERS
por: Lyliana, Nasib, et al.
Publicado: (2020)

Atopy Increases Risk of Psychotic Experiences: A Large Population-Based Study
por: Begemann, Marieke J.H., et al.
Publicado: (2019)

Sexual Dysfunction and Hyperprolactinemia in Male Psychotic Inpatients: A Cross-Sectional Study
por: Johnsen, Erik, et al.
Publicado: (2011)

Women with Schizophrenia-Spectrum Disorders After Menopause: A Vulnerable Group for Relapse
por: Sommer, Iris E, et al.
Publicado: (2022)

The Potential of Cannabidiol as a Treatment for Psychosis and Addiction: Who Benefits Most? A Systematic Review
por: Batalla, Albert, et al.
Publicado: (2019)

Association between gut permeability, brain volume, and cognition in healthy participants and patients with schizophrenia spectrum disorder
por: Scheurink, Toon Anton Willem, et al.
Publicado: (2023)

The association between cytokines and psychomotor speed in a spectrum of psychotic disorders: A longitudinal study
por: Larsen, Jeanette Brun, et al.
Publicado: (2021)

Constructing the Immune Signature of Schizophrenia for Clinical Use and Research; An Integrative Review Translating Descriptives Into Diagnostics
por: Kroken, Rune A., et al.
Publicado: (2019)

Priapism in Antipsychotic Drug Use: A Rare but Important Side Effect
por: Sinkeviciute, Igne, et al.
Publicado: (2012)

Inflammatory monocyte gene signature predicts beneficial within group effect of simvastatin in patients with schizophrenia spectrum disorders in a secondary analysis of a randomized controlled trial
por: Aichholzer, Mareike, et al.
Publicado: (2022)

Cognitive change and antipsychotic medications: Results from a pragmatic rater-blind RCT
por: Anda, Liss, et al.
Publicado: (2021)

Simvastatin Augmentation for Patients With Early-Phase Schizophrenia-Spectrum Disorders: A Double-Blind, Randomized Placebo-Controlled Trial
por: Sommer, Iris E, et al.
Publicado: (2021)

Safe and informed prescribing of psychotropic medication during the COVID-19 pandemic
por: Luykx, Jurjen J., et al.
Publicado: (2020)

Persistent catatonia following epileptic seizures: a case report and systematic literature search
por: Verbraeken, Ragnar, et al.
Publicado: (2018)

What makes the psychosis ‘clinical high risk’ state risky: psychosis itself or the co-presence of a non-psychotic disorder?
por: Hasmi, Laila, et al.
Publicado: (2021)

O4.4. DOES POLYGENIC RISK SCORE FOR SCHIZOPHRENIA MODERATE THE MOMENTARY AFFECTIVE AND PSYCHOTIC REACTIONS TO DAILY-LIFE STRESSORS?
por: Pries, Lotta-Katrin, et al.
Publicado: (2018)

Effectiveness of second-generation antipsychotics: a naturalistic, randomized comparison of olanzapine, quetiapine, risperidone, and ziprasidone
por: Johnsen, Erik, et al.
Publicado: (2010)

M41. TRAJECTORIES AND PREDICTORS OF OUTCOME IN SCHIZOPHRENIA: THE BENEFICIAL ROLE OF AMISULPRIDE
por: Drosos, Petros, et al.
Publicado: (2020)

Are psychiatric disorders risk factors for COVID-19 susceptibility and severity? a two-sample, bidirectional, univariable, and multivariable Mendelian Randomization study
por: Luykx, Jurjen J., et al.
Publicado: (2021)

T206. ANTIPSYCHOTIC EFFECTIVENESS FOCUSING ON INSIGHT
por: Stabell, Lena, et al.
Publicado: (2020)

Pharmacokinetic and urinary profiling reveals the prednisolone/cortisol ratio as a valid biomarker for prednisolone administration
por: Van Meulebroek, Lieven, et al.
Publicado: (2017)

Comorbid Diagnosis of Psychotic Disorders in Borderline Personality Disorder: Prevalence and Influence on Outcome
por: Slotema, C. W., et al.
Publicado: (2018)

Replicated Evidence of Absence of Association between Serum S100B and (Risk of) Psychotic Disorder
por: van der Leeuw, Christine, et al.
Publicado: (2013)

Anti-depressive effectiveness of olanzapine, quetiapine, risperidone and ziprasidone: a pragmatic, randomized trial
por: Kjelby, Eirik, et al.
Publicado: (2011)

Treatment of schizophrenia with antipsychotics in Norwegian emergency wards, a cross-sectional national study
por: Kroken, Rune A, et al.
Publicado: (2009)

T16. SCHIZOPHRENIA SPECTRUM DISORDER: DEPRESSION TRAJECTORIES AND IMMUNE MARKERS
por: Hoprekstad, Gunnhild, et al.
Publicado: (2020)

An update on the efficacy of anti-inflammatory agents for patients with schizophrenia: a meta-analysis
por: Çakici, N., et al.
Publicado: (2019)

Cognitive Profile in Ultra High Risk for Psychosis and Schizophrenia: A Comparison Using Coordinated Norms
por: Anda, Liss, et al.
Publicado: (2019)

The Course of Neurocognitive Changes in Acute Psychosis: Relation to Symptomatic Improvement
por: Anda, Liss, et al.
Publicado: (2016)

S57. TREATMENT SATISFACTION IN ACUTE PHASE PSYCHOSIS: COMPARISON BETWEEN ANTIPSYCHOTIC NAïVE AND PREVIOUSLY MEDICATED PATIENTS
por: Stabell, Lena, et al.
Publicado: (2018)

Comparison of the Efficacy of Combination Therapy of Prednisolone - Acyclovir with Prednisolone Alone in Bell’s Palsy
por: KHAJEH, Ali, et al.
Publicado: (2015)

Prednisolone: Relapse of coronavirus disease-2019 following misuse of prednisolone: case report
Publicado: (2020)

Dipyrone/prednisolone/prednisolone sodium succinate: Acute urticaria and hyperglycaemia: case report
Publicado: (2021)

Coding and Non-Coding RNA Abnormalities in Bipolar Disorder
por: Luykx, Jurjen J., et al.
Publicado: (2019)

Longitudinal clinical and functional outcome in distinct cognitive subgroups of first-episode psychosis: a cluster analysis
por: Oomen, Priscilla P., et al.
Publicado: (2023)

S161. DYNAMIC FUNCTIONAL NETWORK CONNECTIVITY COMPARING AUDITORY VERBAL HALLUCINATIONS IN PSYCHOTIC AND NON-PSYCHOTIC SUBJECTS
por: Marschall, Theresa, et al.
Publicado: (2020)

Hallucinations in acutely admitted patients with psychosis, and effectiveness of risperidone, olanzapine, quetiapine, and ziprasidone: a pragmatic, randomized study
por: Johnsen, Erik, et al.
Publicado: (2013)

QTc Prolongation in Patients Acutely Admitted to Hospital for Psychosis and Treated with Second Generation Antipsychotics
por: Johnsen, Erik, et al.
Publicado: (2013)

The Cannabis Pathway to Non-Affective Psychosis may Reflect Less Neurobiological Vulnerability
por: Løberg, Else-Marie, et al.
Publicado: (2014)

Tactile and Somatic Hallucinations in a Muslim Population of Psychotic Patients
por: Lim, Anastasia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_h1j9frjqhuic6pf29gdkunnb23